Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain

Pain

Volumn 69, Issue 1-2, 1997, Pages 199-201

  Bruera, Eduardo ^a   Pereira, Jose ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer; Fentanyl; Neuropsychiatric

Indexed keywords

FENTANYL; NALOXONE;

ADULT; ARTICLE; CANCER PAIN; CASE REPORT; CLINICAL TRIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PSYCHOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOCARCINOMA; AKATHISIA, DRUG-INDUCED; ANALGESICS, OPIOID; CONFUSION; FENTANYL; HALLUCINATIONS; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; MYOCLONUS; PAIN; PALLIATIVE CARE; STOMACH NEOPLASMS;

EID: 0031044734     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03238-1     Document Type: Article

References (15)

1. Bruera, E. and Miller, M.J., Non-cardiogenic pulmonary edema after narcotic treatment for cancer pain, Pain, 39 (1989) 297-300.
2. de Stoutz, N.D., Bruera, E. and Suarez-Almazor, M., Opioid rotation (OR) for toxicity reduction in terminal cancer patients, J. Pain Symptom Manage., 10 (1995) 378-384.
3. Folstein, M.F., Folstein, S. and McHugh, P.R., 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician, J. Psych. Res., 12 (1975) 189-198.
4. Frenk, H., Watkins, L.R. and Mayer, D.J., Differential behavioural effects induced by intrathecal microinjection of opiates: comparison of convulsive and cataleptic effects produced by morphine, methadone, and D-Ala-Methionine-enkephalinamide, Brain Res., 299 (1984) 41-42.
5. Henderson, G.L., Fentanyl-related deaths: demographics, circumstances and toxicology of 112 patients, J. Forensic Sci., 36 (1991) 422-433.
6. Inturrisi, C.E., Opioid analgesic therapy in cancer pain. In: K.M. Foley, J.J. Bonica, V. Ventafridda (Eds.), Advances in Pain Research and Therapy, Raven Press, New York, 16 (1990) pp. 133-154.
7. Koide, S., Onishi, H., Yamagami, S., and Kawakita, Y., Effects of morphine and D-Ala2-D-Leu5-enkephalin in the seizure-susceptible E1 mouse, Neurochem. Res., 17 (1992) 779-783.
8. Koide, S., Onishi, H., Katayama, M. and Yamagami, S., Endogenous methionine enkephalin may plan an anticonvulsant role in the seizure-susceptible E1 mouse, Neurochem. Res., 18 (1993) 1259-1262.
9. Lauretti, G.R., Ahmad, I. and Pleuvry, B.J., The activity of opioid analgesics in seizure models utilizing N-methyl-DL-aspartic acid, kainic acid, bicuculline and pentylenetetrazole, Neuropharmacology, 33 (1994) 155-160.
10. Marquardt, K.A. and Tharratt, R.S., Inhalation abuse of fentanyl patch, J. Toxicol. Clin. Toxicol., 31 (1994) 75-78.
11. Martin, M., Hecker, J., Clark, R., Frye, J., Jehle, D., Lucid, E.J. et al., China White epidemic: an eastern United States emergency department experience, Ann. Emerg. Med., 20 (1991) 158-164.
12. Sjogren, P., and Erikson, J., Opioid toxicity, Curr. Opin. Anesthesiol., 7 (1994) 465-469.
13. Sjogren, P., Jensen, N.H. and Jensen, T.S., Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists, Pain, 59 (1994) 313-316.
14. Skinner, M. and Thompson, A., Pharmacologic considerations in the treatment of substance abuse (review), Soc. Med. J., 85 (1992) 1207-1219.
15. Thomas, J., Nores, W.L., Kenigs, V., Olson, G.A. and Olson, R.D. Picrotoxin-induced seizures modified by morphine and opiate antagonists, Pharmacol. Biochem. Behav., 45 (1993) 615-617.